Response to letter by tsuda

Stroke

Volumn 40, Issue 7, 2009, Pages

  McCarthy, Claudia A ^a   Vinh, Antony ^a   Callaway, Jennifer K ^b   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BRAIN ISCHEMIA; ENZYME PHOSPHORYLATION; HYPERTENSION; LETTER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE;

EID: 67650082740     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.555532     Document Type: Letter

References (12)

1. McCarthy CA, Vinh A, Callaway JC, Widdop RE. AT2R stimulation causes neuroprotection in a conscious rat model of stroke. Stroke. 2009; 40:1482-1489.
2. Widdop R, Jones E, Hannan R, Gaspari T. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol. 2003;140:809-824.
3. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther. 2008;120:292-316.
4. Ito T, Yamakawa H, Bregonzio C, Terron J, Falcon-Neri A, Saavedra J. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke. 2002;33:2297-2303.
5. Yamakawa H, Jezova M, Ando H, Saavedra JM. Normalization of endo-thelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab. 2003;23:371-380.
6. Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E, Saavedra JM. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke. 2006;37:1271-1276.
7. Vincent JM, Kwan YW, Chan SL, Perrin-Sarrado C, Atkinson J, Chillon JM. Constrictor and dilator effects of angiotensin II on cerebral arterioles. Stroke. 2005;36:2692-2695.
8. Hiyoshi H, Yayama K, Takano M, Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension. 2005;45:967-973.
9. Yayama K, Hiyoshi H, Imazu D, Okamoto H. Angiontensin II stimulation endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension. 2006;48: 958-964.
10. Vinh A, Widdop R, Drummond GR, Gaspari TA. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Cardiovasc Res. 2008;77:178-187.
11. Li J, Culman J, Hortnagl H, Zhao Y, Gerova N, Timm M, Blume AK, E Unger T, Zimmermann M, Seidel K, Dirnagl U, Unger T. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005;19:617-619.
12. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T, Horiuchi M. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation. 2004;110: 843-848.